MDM2 Non-Genotoxic Inhibitors as Innovative Therapeutic Approaches for the Treatment of Pediatric Malignancies

E-ISSN： 1875-533x|20|17|2226-2236

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.17, 2013-06, pp. : 2226-2236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2100-2110

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies

Current Medicinal Chemistry, Vol. 20, Iss. 17, 2013-06 ,pp. : 2254-2271

Bentham Science Publishers

Access to resources Recommend Favorite

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 749-772

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Innovative Approaches for the Management of Pediatric Malignancies)

Current Medicinal Chemistry, Vol. 20, Iss. 17, 2013-06 ,pp. : 2155-2156

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Innovative Therapeutic Approaches for the Treatment of Pediatric Autoimmune and Inflammatory Diseases)

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5728-5728

Bentham Science Publishers

Access to resources Recommend Favorite